Use of CDMAS to analyze date to determine the effectiveness of influenza vaccine in persons 65 and older in preventing pneumococcal bacteremia; obtain baseline rates of pneumococcal bacteremia, calculation of case-fatality rates; and calculation of Medicare dollar savings.
Showing the most recent 10 out of 509 publications